Quest Diagnostics Incorporated
Quest Diagnostics Incorporated (DGX): 3 pipeline candidates · ~6 mo cash runway. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
6.2 months
N/A
Lead: Approved
3 candidates
N/A
0 buys · 18 sells (180d)
A transparent, data-derived signal for Quest Diagnostics Incorporatedacross cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$22.5B
Cash
$393.0M
Quarterly Burn
$504.0M
Runway
6.2 mo
Revenue
$2.9B
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (3 candidates)
| Drug | Phase |
|---|---|
| autoimmune analyzer | Approved |
| quest ad-detect | Approved |
| quest diagnostics aavrh74 antibody elisa cdx | Approved |
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
1,058
Total value held
$18.34B
| Holder | Shares | Value |
|---|---|---|
| vanguard capital management llc | 14,291,344 | $2.80B |
| blackrock, inc. | 9,172,292 | $1.80B |
| vanguard portfolio management llc | 6,081,400 | $1.19B |
| state street corp | 5,380,821 | $1.05B |
| geode capital management, llc | 3,086,308 | $602.7M |
| morgan stanley | 2,479,720 | $486.0M |
| edgepoint investment group inc. | 2,243,869 | $439.8M |
| dimensional fund advisors lp | 1,949,535 | $382.1M |
| grantham, mayo, van otterloo & co. llc | 1,883,024 | $369.0M |
| victory capital management inc | 1,846,336 | $361.8M |
Showing top 10 of 1,058 institutional holders of Quest Diagnostics Incorporated. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in Quest Diagnostics Incorporated's pipeline?
Quest Diagnostics Incorporated (DGX) has 3 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is Quest Diagnostics Incorporated's lead drug candidate?
Quest Diagnostics Incorporated's most advanced tracked candidate is autoimmune analyzer (Approved) for Autoimmune disorders screening.
What is Quest Diagnostics Incorporated's cash runway?
Based on its most recent reported cash balance and quarterly burn rate, Quest Diagnostics Incorporated has approximately 6.2 months of cash runway.
What is Quest Diagnostics Incorporated's market capitalization?
Quest Diagnostics Incorporated's market capitalization is approximately $22.5B.
Who is the CEO of Quest Diagnostics Incorporated?
Mr. James E. Davis is the chief executive officer of Quest Diagnostics Incorporated (DGX).
Get the full picture on Quest Diagnostics Incorporated
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.